Statera BioPharma OverviewStatera BioPharma Net Income
Profitability analysis for STAB.
Quarterly Net Income
-$5.16M
↑ 59.44% YoY
As of Sep 2022
Annual Net Income (TTM)
-$104.34M
↓ 614.05% YoY
Trailing 12 months ending Sep 2022
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...